FDA Begins cGMP Reinspection Of Teligent’s Key Facility
US Firm’s Buena Site Received Warning Letter Late In 2019
Teligent is relying upon the FDA approval of its manufacturing capacity at Buena, New Jersey to reintroduce its products in the market and “significantly expand” its production capabilities within the sterile injectables segment.